首页> 外文期刊>The Journal of pediatrics >Development and validation of the pediatric liver transplantation quality of life: A disease-specific quality of life measure for pediatric liver transplant recipients
【24h】

Development and validation of the pediatric liver transplantation quality of life: A disease-specific quality of life measure for pediatric liver transplant recipients

机译:儿科肝移植质量的发展与验证:儿科肝移植受者的疾病特异性生活措施

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objectives To develop and validate a Pediatric Liver Transplantation Quality of Life (PeLTQL) questionnaire via an international multicenter collaboration. Study design Item generation with 146 child and/or parent interviews (92 pediatric liver transplantation [LT] recipients) and 3 focus groups generated over 300 items. An item reduction questionnaire with 76 questions was completed by 320 participants (212 pediatric LT recipients). Results Frequency-importance product ranking, questionnaire formatting, and pre-testing resulted in a 26-item PeLTQL questionnaire. Factor analysis identified 3 domains: future health, coping and adjustment, and social-emotional. The validation phase was completed by 133 (46% male) LT recipients (aged 8-18 years). Internal consistency (Cronbach ? 0.86) and test-retest reliability (intraclass correlation coefficient = 0.85) were excellent. Mean patient PeLTQL score was 69.54 ?3.06. Construct validity with validated tools identified significant correlations between mean PeLTQL scores and (1) Pediatric Quality of Life Inventory generic (r = 0.64, P <.001); (2) Pediatric Quality of Life Inventory transplant (r = 0.73, P <.001); and (3) Screen for Child Anxiety Related Disorders (r = -0.57, P <.001) scores. Only 17/3458 (0.5%) questions were left blank. A Flesch-Kincaid grade level of 5.4 was calculated as a measure of the PeLTQL readability statistic. Conclusions The PeLTQL is a valid and reliable novel 26-item disease-specific health related quality of life instrument for LT recipients aged 8-18 years. Low PeLTQL scores can identify patients at risk for childhood anxiety and depression. The tool is now ready for broad use in both clinical practice and clinical interventional trials.
机译:目的通过国际多中心协作,开发和验证儿科肝移植质量(PELTQL)问卷。研究设计项目生成146名儿童和/或家长访谈(92个儿科肝移植[LT]受者)和3个焦点小组产生超过300项。有76个问题的项目减少问卷由320名参与者(212个儿科LT受者)完成。结果频率 - 重要产品排名,问卷格式,和预测试导致了26项PeltQL问卷调查问卷。因子分析确定了3个域名:未来的健康,应对和调整,以及社会情感。验证阶段由133名(46%的男性)LT受者(8-18岁)完成。内部一致性(Cronbach?0.86)和测试 - 保持性可靠性(腹部相关系数= 0.85)是优异的。平均患者PELTQL得分为69.54?3.06。构建有验证工具的有效性鉴定了平均PELTQL分数与(1)寿命常见的PERIATIC(R = 0.64,P <.001)之间的显着相关性; (2)寿命库存移植的儿科品质(r = 0.73,p <.001); (3)儿童焦虑相关疾病的筛选(r = -0.57,p <.001)分数。只有17/3458(0.5%)问题留空。氟氯虫蛋白级等级为5.4,作为PELTQL可读性统计量的衡量标准。结论PELTQL是一个有效且可靠的新型26项疾病特异性健康状况,用于LT 8-18岁的受人员的LT受害者。低PELTQL评分可以识别患有儿童焦虑和抑郁症的患者。该工具现在准备好广泛使用临床实践和临床介入试验。

著录项

  • 来源
    《The Journal of pediatrics》 |2014年第3期|共9页
  • 作者单位

    Sick Kids Transplant Center Hospital for Sick Children University of Toronto Toronto ON Canada;

    Social Work University of Calgary Calgary AB Canada;

    Pediatric Liver Center Kings College London King's College Hospital London United Kingdom;

    Pediatrics Cincinnati Children's Hospital Medical Center Cincinnati OH United States;

    Pediatrics Royal Children's Hospital Brisbane QLD Australia;

    Pediatrics Children's Hospital at Westmead Sydney NSW Australia;

    Pediatrics Stollery Children's Hospital Edmonton AB Canada;

    Pediatrics British Columbia Children's Hospital Vancouver BC Canada;

    Cancer Clinical Trials Unit University College London Hospital London United Kingdom;

    Pediatrics Dalhousie University IWK Health Centre Halifax NS Canada;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 儿科学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号